Shipment term

Isracann Bioscience facilitates the shipment of cannabis genetics to Israel – Isracann Biosciences (OTC:ISCNF)

Israelcann Biosciences Inc. ISCNF IPOT A has ease his first shipment of cannabis varieties to Israel.

The agreement for genetics is directly between United Greeneries Ltda licensed Canadian producer of artisanal cannabis, and Intelicanna, a licensed producer and brand of Israeli medical cannabis. Three initial strains are included in the deal, with the possibility of additional strains. Under a revenue-sharing agreement, United Greeneries will be responsible for cultivation and genetic support, with in-country support provided by Isracann.

“Israel is the largest importer of Canadian cannabis in the world,” said CEO Philippe Floucault. “The main reason for this is that the domestic market does not have the high THC strains available outside the country. I am delighted that Isracann, through our agreement with United Greeneries, was able to arrange this shipment of genetics to Intelicanna and we look forward to expanding this offering.United Greeneries Ltd. continues to supply some of the most potent Sativa and Indica strains to the Canadian domestic market and seeks to help Intelicanna do the same in Israel.

Since 2021, Intelicanna has been cultivating and selling medicinal cannabis for the Israeli market under the Intelicanna brand. Their HaSharon facility comprises 5,500 m2 hybrid greenhouse with full light, shade and climate control.

Floucault continued: “This first shipment should arrive in Israel in the short term. We worked with Intelicanna to get everything ready to receive the clones and speed up the scaling process to full production. In a short time, quality Canadian cannabis will be grown in Israel. »

picture by CRISTALWEED Cannabis on Unsplash

Related News

The Praesidio of Isracann expands its distribution network of natural health products: Inks Deal With Pure Integrative Pharmacy

Cannabis company Isracann Biosciences raises $234,000 in first tranche of private placement

Praesidio Health, Subsidiary of Isracann Biosciences, Submits NPNs to Health Canada